Shivanthan Shanthikumar on Muck Rack

Shivanthan Shanthikumar

As seen in: Wiley Online Library, Archives of Disease in Childhood, The Conversation, Thorax, Medical Xpress, medRxiv, European Respiratory Journal, Texas Medical Center, Philippine Canadian Inquirer, Medicine Today and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shivanthan

Contact Shivanthan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?

|
By Shivanthan Shanthikumar
| Texas Medical Center
Hematopoietic stem cell transplantation (HSCT) is undertaken in children with the aim of curing a range of malignant and non-malignant conditions. Unfortunately, pulmonary complications, especially bronchiolitis obliterans syndrome (BOS), are a significant source of morbidity and mortality post-HSCT. Currently criteria developed by a National Institutes of Health (NIH) working group are used to diagnose BOS in children post-HSCT.
Open in Who Shared Issue with article?

Remission in Children Receiving Biologic Therapy for Severe Asthma

|
By Eilidh Bruce, Shivanthan Shanthikumar, Yi Cheau Chua
| Wiley Online Library Verified
To the Editor, Biologic therapy has transformed the management of severe asthma, with benefits including reduced asthma exacerbations and hospital admissions, along with improved asthma control, quality of life, and lung function [1]. Often, patients are also able to reduce background asthma therapy. The response to biologic therapy can be so profound that some patients are said to be in remission.
Open in Who Shared Issue with article?

Evaluating the Use of iPSC‐Derived Models in Understanding the Pathogenesis of Childhood Interstitial Lung Disease

|
By Swetha Jinson, Shivanthan Shanthikumar, Rhiannon B. Werder
| Wiley Online Library Verified
1 Introduction Childhood interstitial lung diseases (chILD) encompass a heterogeneous spectrum of respiratory conditions, primarily affecting children under 2 years. These conditions are associated with high mortality and morbidity from infancy [1]. chILD was initially thought to be very rare, however, more recent studies have reported a higher prevalence than prior studies [2, 3]. The pathogenesis of chILD is varied and often unknown.
Open in Who Shared Issue with article?
See all 24 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified